Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche Gets Priority Review for Avastin Label Expansion
Yahoo/Zacks.com
Wed, 07/16/14 - 05:18 pm
Tags:
Roche, Avastin, cervical cancer
Roche, Exelixis Skin Cancer Drug Delays Tumor Progression
TheStreet.com
Mon, 07/14/14 - 10:32 am
Tags:
Roche, Exelixis, melanoma, Cobimetinib, Zelboraf
Roche Collaborates with Merck KGaA
Yahoo/Zacks
Sat, 07/12/14 - 11:08 am
Tags:
Roche, Merck KGaA, diagnostics
Roche biotech drug offers new way to fight asthma
Yahoo/Reuters
Wed, 07/2/14 - 04:50 pm
Tags:
Roche, asthma, quilizumab
Roche's Deal Should Sound Early Warning
WSJ Online
Wed, 07/2/14 - 09:53 am
Tags:
Roche, M&A, Seragon, breast cancer
Roche to buy U.S. biotech firm Seragon for $725 million
Yahoo/Reuters
Wed, 07/2/14 - 02:45 am
Tags:
Roche, M&A, Seragon
GSK expects to meet flu vaccine demand but even short interruptions can be costly
Fierce Pharma
Wed, 06/25/14 - 05:31 pm
Tags:
vaccines, flu vaccines, GSK, Flulaval Quadrivalent, Roche, Novartis, Sanofi
Pharma’s Huge Bet on Immunotherapies
Motley Fool
Wed, 06/25/14 - 07:35 am
Tags:
immunotherapy, anti-PD-1 immunotherapy, anti-PD-L1, MK-3475, Merck, nivolumab, Roche, Bristol-Myers Squibb
Report: Roche, Novartis among Swiss companies with highest pay gaps
Fierce Pharma
Tue, 06/24/14 - 05:20 pm
Tags:
executive pay, Roche, Novartis
What Will Happen When Biotech Drugs Go Generic?
Forbes
Fri, 06/13/14 - 10:58 am
Tags:
biotech, generics, Amgen, Roche, Biogen Idec, Eli Lilly, Bristol-Myers Squibb, Sanofi, Novartis, Sandoz, Omnitrope, Genotropin
Roche's Purchase Of Genia A Long-Term Move
Seeking Alpha
Fri, 06/13/14 - 09:20 am
Tags:
Roche, Genia Technologies, M&A
Italy's move to fund unapproved use of Roche's Avastin alarms the industry
Fierce Pharma
Wed, 06/11/14 - 10:47 am
Tags:
Italy, Roche, Avastin, age-related macular degeneration
FirstWord List: Top 15 pharma and lead product dependency
First Word Pharma
Mon, 06/9/14 - 10:35 am
Tags:
Teva, AbbVie, Boehringer Ingelheim, GSK, Sanofi, Amgen, Eli Lilly, JNJ, AstraZeneca, Roche, Novartis, Merck, Pfizer, Takeda, Bristol-Myers Squibb
This Week in Biotech: A Trifecta of Disappointment Mars ASCO While Biogen Scores a Big Victory
Motley Fool
Mon, 06/9/14 - 09:17 am
Tags:
ASCO, Biogen Idec, Elocate, neratinib, Puma Biotechnology, CO-1686, Clovis Oncology, Tykerb, GSK, Roche
ASCO 2014: Doubling Down on Next-Gen Cancer Drugs
Motley Fool
Tue, 06/3/14 - 12:26 pm
Tags:
ASCO, Roche, Amgen, blinatumomab, AstraZeneca, cancer, biospecific antibodies
Using Avastin for Eye Disorder Could Save U.S. $3 Billion
Bloomberg
Mon, 06/2/14 - 06:13 pm
Tags:
Avastin, Roche, Lucentis, age-related macular degeneration, diabetic macular edema
Bristol Defends Data; Roche Shines In Cancer Showdown
Investors.com
Mon, 06/2/14 - 02:51 pm
Tags:
Roche, Bristol-Myers Squibb, nivolumab, Yervoy, melanoma, MPDL3280A, bladder cancer, ASCO
Roche Agrees to Buy Genia Technologies for Up to $350 Million
Bloomberg
Mon, 06/2/14 - 11:02 am
Tags:
Roche, Genia Technologies, M&A, gene sequencing
Cancer Conference Winners And Losers
Forbes
Mon, 06/2/14 - 10:38 am
Tags:
ASCO, GSK, Puma Biotechnology, Merck, Roche, Bristol-Myers Squibb, Kite, Novartis, Juno Therapeutics, Eli Lilly, Clovis Oncology, AstraZeneca
Roche returns to antibiotic research as superbug threat grows
Yahoo/Reuters
Mon, 06/2/14 - 10:33 am
Tags:
Roche, antibiotics, superbugs, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.